key: cord-0711000-j0gng56n authors: Berber, Engin; Sumbria, Deepak; Rouse, Barry T. title: Could targeting immunometabolism be a way to control the burden of COVID-19 infection? date: 2021-01-20 journal: Microbes Infect DOI: 10.1016/j.micinf.2021.104780 sha: 25f280ef66f163ff59e83b23d7e21744ab404879 doc_id: 711000 cord_uid: j0gng56n This review portrays the metabolic consequences of Covid-19 infection at different stages of the clinical syndrome. It also describes how events can change when patients with metabolic problems are infected and the effects that diet and nutrition might play to influence the outcome of infection. We also discuss the types of maneuvers that could be used to reshape metabolic events and question if this approach could be a practical therapy used alone or in combination with other approaches to reduce the burden of Covid-19 infection. In the past year, the whole world has become aware of SARS-CoV-2 (Covid-19). Thus perhaps around September 2019, humans became infected by a novel passenger coronavirus of 48 bats, Covid-19 and this has led to a pandemic, which as of early January 2021, has led to 84 49 million confirmed infections with at least 1.8 million deaths [1] . No country that tests for Covid-50 19 has escaped infection and currently the virus is spreading dramatically in most places. This 51 state of affairs is likely to continue unless the recently developed vaccines, or other ways to 52 control the infection, prove effective. The main mission of this review is to describe metabolic 53 changes set into play when viruses infect us and to discuss the various ways host metabolism 54 affects the outcome of infection focusing on Covid-19. We also evaluate if manipulating 55 metabolism at various stages of the Covid-19 induced syndrome provides a useful approach to 56 limit the consequences of the infection. As with all infections, the outcome following exposure to Covid-19 is highly variable with 58 inapparent effects the most frequent, but all too commonly a severe debilitating often lethal dies. This is the usual fate of cells infected with Covid-19 and cells such as alveolar epithelial 110 cells must be replaced or their function, which involves gas exchange and production of 111 surfactants needed for lung function, will cease [13] . Recording Another approach used to record the metabolic consequences of Covid-19 infection has 128 been to perform ex vivo studies on bronchial lavage cells and blood monocytes from Covid-19 129 patients comparing any metabolic changes to normal controls using a range of measurements 130 that include single cell RNA-seq, metabolomics and transcriptomic. One such study using single 131 J o u r n a l P r e -p r o o f cell RNA-seq on bronchial alveolar cells revealed significant increases in metabolites involved in 132 glycolysis that included HIF-1α and genes involved in the induction of oxidative stress ( Fig.1 Curiously, in a model study where PPARy expression was ablated in mouse adipocytes, animals 141 developed fatty livers and several metabolic changes. These included elevated levels of blood 142 glucose, insulin resistance, as well as increased plasma free fatty acids (FFAs) and triglyceride 143 levels [21, 22] . In another mouse study, when PPARγ gene expression was deleted in 144 mononuclear cells, mice became more susceptible to influenza virus infection (Covid-19 was 145 not studied) and this outcome could be rescued by therapy with a PPARγ agonist [22] . We 146 anticipate that switching on and enhancing PPAR function might be a useful approach to reduce 147 the burden of Covid-19 disease. The fact that obesity is a susceptibility factor for Covid-19 morbidity and mortality is well 295 accepted, but why this is the case is not fully understood. However, it is well known that There is no conflict of interest to declare. WHO. Coronavirus disease (COVID-19) dashboard. 2021. Accessed 5 A metabolic handbook for the COVID-19 pandemic Virus infections and host metabolism-can we manage COVID-19: Disease, or no disease? -that is the question. It`s the 421 dose stupid! Microb Infect 2021 COVID-19 illness in native and immunosuppressed states: A 423 clinical-therapeutic staging proposal. The Journal of heart and lung transplantation : the official 424 publication of the International Society for Cytokine storms: Understanding COVID-19 Cytokine storm Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March Lipoatrophy and severe metabolic 454 disturbance in mice with fat-specific deletion of PPARγ. Proceedings of the National Academy of 455 Sciences of the United States of CoV-2-infected host cells reveals therapy targets The SARS-CoV-2 459 transcriptional metabolic signature in lung epithelium Immune 461 responses during COVID-19 infection The pathogenesis and treatment of the `cytokine storm' in COVID-463 19 A neutralizing monoclonal antibody for hospitalized patients with 465 COVID-19 Nocturnal oxygen therapy as an option for early 467 COVID-19 Lung surfactant for pulmonary barrier 469 restoration in patients with COVID-19 pneumonia Recovery from acute kidney injury with diabetic ketoacidosis following SARS-471 CoV-2 infection: a case report and literature review Hypertriglyceridemia-related pancreatitis in patients with type 2 473 diabetes: Links and risks Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-476 mortem study Sustained cellular 478 immune dysregulation in individuals recovering from SARS-CoV-2 infection A randomized, controlled trial of vitamin A in children with severe 481 measles The role of 483 short-chain fatty acids in the interplay between diet, gut microbiota, and host energy 484 metabolism The impact of dietary fiber on gut microbiota 486 in host health and disease Effect of oral 488 l-Glutamine supplementation on COVID-19 treatment ) levels in patients hospitalized with COVID-19 are associated with 491 greater disease severity The use of IV vitamin 493 C for patients with COVID-19: a case series Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four 495 patients Icosapent ethyl -a successful 498 treatment for symptomatic COVID-19 infection COVID-19 alters thinking and management in metabolic diseases COVID-19 519 in people with diabetes: understanding the reasons for worse outcomes A 522 pragmatic approach to inpatient diabetes management during the COVID-19 pandemic COVID-19: diabetes and death. A call to action COVID-19 and 526 diabetes: A complex bidirectional relationship COVID-19 and diabetes: Insulin requirements parallel 528 illness severity in critically unwell patients COVID-19 and diabetes mellitus: from 530 pathophysiology to clinical management The effect of short-term hyperglycemia on the innate 532 immune system Role of adaptive and innate immunity in type 534 2 diabetes mellitus SARS-CoV-2 receptor 536 angiotensin i-converting enzyme type 2 (ACE2) is expressed in human pancreatic β-cells and in Relationship between natural killer 539 cell activity and glucose control in patients with type 2 diabetes and prediabetes High glucose modulates IL-6 mediated immune homeostasis through impeding neutrophil 543 extracellular trap formation High glucose impairs superoxide production from 545 isolated blood neutrophils Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas 548 hyperinsulinemia inhibits fibrinolysis during human endotoxemia Modification of 550 β-defensin-2 by dicarbonyls methylglyoxal and glyoxal inhibits antibacterial and chemotactic 551 function in vitro Impaired CD4 and CD8 T cell 553 phenotype and reduced chemokine secretion in recent-onset type 1 diabetic children CD39 expression on Treg and Th17 cells is associated with 557 metabolic factors in patients with type 2 diabetes Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with 560 COVID-19 in the new york city area Individuals with 562 obesity and COVID-19: A global perspective on the epidemiology and biological relationships Prevalence of obesity 565 among adult inpatients with COVID-19 in France Obesity in 567 patients younger than 60 years is a risk factor for COVID-19 hospital admission. Clinical 568 infectious diseases : an official publication of the Infectious Diseases Society of Obesity and COVID-19 severity in a 571 designated hospital in shenzhen, china Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation, 573 and Cytokine Amplification in Coronavirus Disease Obesity is a risk factor for severe COVID-19 575 infection Obesity is 577 associated with impaired immune response to influenza vaccination in humans Protective role of statins in COVID 19 patients: 580 importance of pharmacokinetic characteristics rather than intensity of action. Internal and 581 emergency medicine 2020 Dietary 583 fiber confers protection against Flu by shaping Ly6c(-) patrolling monocyte hematopoiesis and 584 CD8(+) T Cell metabolism Th17 and Treg balance in collagen antibody-induced arthritis Supplementing the diet with sodium propionate 588 suppresses the severity of viral immuno-inflammatory lesions Manipulating glucose metabolism during 591 different stages of viral pathogenesis can have either detrimental or beneficial effects Protective effects of High-fat diet (45% of calories from fat) Adipose tissue increases M1 macrophages and higher expression of TNF-α, IL-6 and iNOS.[80]Standard diet (4.5% fat) Adipose tissue mainly has M2 macrophages that express arginase-1, and IL-10.High fat diet (60 Kcal% fat)Lower level of hematopoiesis, higher level of oxidative stress and overexpression of Growth factor independence 1.[81]Normal chow diet (13 Kcal% fat) Expresses higher level of hematopoiesis, reduced oxidative stress and normal expression of Gfi1. High fat diet (60% Kcal from fat)Reduced lymphatic flow and migration of dendritic cell to local lymph nodes. Low level of CD4 and CD8 T cells and higher level of B and macrophages in lymph nodes.[82]Normal chow diet (13% kcal from fat)Normal lymphatic flow and migration of dendritic cell to local lymph nodes. High level of CD4 and CD8 T cells and low level of B and macrophages in lymph node. High fat diet (60% calories from fat) Low level of naive and CD4 T cells, reduced levels of IFN-γ, IL-6, TNF and TGF-β1.[83] Low fat diet (4.5% fat) High levels of naive and CD4 T cells, higher levels of IFN-γ, IL-6, TNF and TGF-beta1.High fat diet (60% calorie) More prone to reinfection by influenza due to lower level of memory T cells in lungs.[84]